|
|
|
| home > white papers > Pharmaceutical Companies: Outsourcing Combination Product Manufacturing - Phillips-Medisize |
|
|
 WHITE PAPERS |
|
Phillips-Medisize
|
|
Pharmaceutical Companies: Outsourcing Combination Product Manufacturing
|
|
Combination products are therapeutics that combine two or more products (drug/device, biologics/device, biologics/drugs, or drug/device/biologics), regulated and sold as a single unit. Examples of combination products include drug-coated implantable devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Datwyler celebrates official opening of its new production plant with First Line standard in Middletown, Del
• The new facility in Middletown, Del., is Datwyler’s third facility with First Line standard which will be catering to the markets in North and South America
• Approximately 120 jobs will be created, with the majority staffed from the local community
• With the Middletown facility, Datwyler will be able to increase its global First Line production by 50 percent by 2020
• First Line is specially designed to manufacture biotech and pharmaceutical elastomer components in a fully integrated good manufacturing practice (GMP) environment
More info >> |
|
 |
White Papers |
 |
|
Managing GxP Environmental Systems to Ensure Data Integrity
Vaisala Ltd
More info >> |
|
 |
Industry Events |
 |
BioTrinity 2019
30 April - 1 May 2019, etc.venues 155 Bishopsgate, London EC2M 3YD
BioTrinity 2019 is taking
place from the 30th April – 1stMay at etc.venues 155 Bishopsgatein London. Now in its 13th year, BioTrinity remains the leading Life Sciences Biopartnering
and Investment conference in Europe, and generates unrivalled opportunities for
life science companies, academics, investors, and major pharmaceutical players
to come together to do deals and establish collaborations.
More info >> |
|
|
|
